Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Black Bird Biotech Posts Full MiteXstreamTM Biopesticide Efficacy Report

By: Black Bird Biotech, Inc. via AccessWire

March 03, 2022 at 08:45 AM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

The Company Prepares to Launch a Major Sales Initiative

FLOWER MOUND, TX / ACCESSWIRE / March 3, 2022 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstream^TM biopesticide, today announced that it had posted the MiteXstream^TM Efficacy Report published by British Columbia laboratory Botanical Research in Motion (BRIM) at MiteXstream.com.

"The power of MiteXstreamTM has now been validated and sets the stage for our marketing campaign to introduce this revolutionary product worldwide. This BRIM Report coupled with the knowledge base we built over three-plus years of using it allows us to build a powerful sales program," said Fabian Deneault, developer of MiteXstreamTM and President of BBBT. He added, "We encourage a full reading of this report to understand the products' high efficiency and tremendous market potential."

According to market reports, the global market for biopesticides and synthetic pesticides reached $78.7 billion by 2021, growing at a compound annual growth rate (CAGR) of 5.5% from 2016 to 2021. Black Bird is in the process of assembling a top-notch team of industry professionals to work towards large industrial contracts and potential joint ventures in markets worldwide.

For news and updates, shareholders, prospective investors and prospective business partners are encouraged to follow @BBBT_Corporate on Twitter and @BlackBirdBiotech on Instagram. Also visit BBBT's corporate website, BlackBirdBiotech.com, for additional information about the company.

About BBBT

Black Bird Biotech is positioned to exploit market segments with powerful, re-imagined biotech products. Its EPA-registered biopesticide, MiteXstream^TM, eradicates mites and similar pests, including spider mites (a lethal pest in cannabis, grapes, hops, coffee, strawberries and many other agricultural crops), and eliminates molds and mildews. MiteXstream^TM is a pesticide, but it is not a poison - it's a pesticide re-imagined. The MiteXstream^TM Edge: use through the day of harvest without concern for residual "pesticide" violations, including in state cannabis testing. MiteXstream^TM is the foundational element of the company that carries vast potential worldwide as a highly effective, safe and extremely cost-effective replacement for many traditional "poisonous" pesticides.

Forward Looking Statements:

This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact:

Eric Newlan
Vice President
833-223-4204
eric@newlanpllc.com
BlackBirdBiotech.com

SOURCE: Black Bird Biotech, Inc.

View source version on accesswire.com:
https://www.accesswire.com/691402/Black-Bird-Biotech-Posts-Full-MiteXstreamTM-Biopesticide-Efficacy-Report

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	237.50	-8.50 (-3.46%)
AAPL	295.95	-3.29 (-1.10%)
AMD	512.48	+512.43 (1010708.68%)
BAC	56.53	+56.52 (1009364.29%)
GOOG	362.10	-9.00 (-2.43%)
META	567.58	-32.63 (-5.44%)
MSFT	378.91	-14.92 (-3.79%)
NVDA	204.65	-2.76 (-1.33%)
ORCL	183.53	-4.80 (-2.55%)
TSLA	396.38	-8.28 (-2.05%)